The first randomized sham-controlled study of renal denervation in patients with mild, but drug-resistant, hypertension found a significant reduction in systolic blood-pressure in the per-protocol analysis, but showed no significant difference in the intention to treat population.
Steffen Desch, MD, of the University of Schleswig-Holstein, Lübeck, Germany, presented results from a sham-controlled trial of Medtronic PLC’s Symplicity Flex renal denervation catheter in patients with mild hypertension...